F I N A L E X A M I N AT I O N P R E P A R AT I O N ·
VERIFIED ANSWERS
NR 566 Final Exam
Questions & Answers
Two hundred verified multiple-choice
questions with detailed rationales covering
advanced pharmacology for care of the family
across the lifespan — aligned with 2026–2027
clinical practice guidelines and course
objectives.
Advanced Pharmacology for Care of the
Family
200 Questions | 10 Sections | Prescriptive Practice
Rationales
L AT E S T 2 0 2 0 2 7 E D I T I O N
,NR 566 Final Exam | Advanced Pharmacology for Care of the Family
Table of Contents
NR 566 / NR566 Final Examination Preparation and Verified Answer Development | Two Hundred Questions Across
Ten Sections, Latest Edition
Section 1: Pharmacokinetics and Pharmacodynamics Across the Lifespan 2
Section 2: Pharmacogenomics and Precision Medicine 10
Section 3: Cardiovascular Pharmacology 14
Section 4: Respiratory Pharmacology 24
Section 5: Endocrine Pharmacology 30
Section 6: Central Nervous System Pharmacology 39
Section 7: Infectious Disease Pharmacology 47
Section 8: Gastrointestinal and Genitourinary Pharmacology 55
Section 9: Pain Management and Anti-Inflammatory Pharmacology 60
Section 10: Special Populations, Safety, and Prescriptive Authority 68
Advanced Practice Nursing Education | Edition 1
,NR 566 Final Exam | Advanced Pharmacology for Care of the Family
SECTION 1
Section 1: Pharmacokinetics and Pharmacodynamics Across the
Lifespan
Absorption, Distribution, Metabolism, Excretion, and Age-Related Considerations
Questions 1 - 20 | 20 Questions | Multiple Choice (A-D), One Best Answer
Q1: A 78-year-old woman with chronic kidney disease (estimated creatinine clearance 28 mL/min), type 2
diabetes, and hypertension requires a new prescription for a direct-acting oral anticoagulant after atrial
fibrillation is diagnosed. As the APRN, which pharmacokinetic principle is the MOST important
determinant of your final dosing decision?
A. Hepatic enzyme induction accelerates drug metabolism in older adults with renal disease
B. Increased gastric pH in older adults substantially reduces drug absorption of DOACs
C. Hypoalbuminemia increases the volume of distribution of all oral anticoagulants by 50%
D. Renal excretion is the primary elimination pathway for apixaban and dabigatran, requiring dose
reduction or alternative selection [CORRECT]
Correct Answer: D
Rationale: Dabigatran (approximately 80%) and apixaban (approximately 27%) rely partly or largely on renal
excretion, so reduced creatinine clearance mandates dose reduction (e.g., apixaban 2.5 mg twice daily when 2 of 3
criteria are met) or selection of an alternative. Option A describes enzyme induction, which is not characteristic of
aging; metabolism of phase I reactions typically declines with age. Option B is incorrect because DOAC absorption
is not meaningfully dependent on gastric pH, which does rise in older adults but affects only certain drugs such as
ketoconazole. Option C overstates the effect of hypoalbuminemia and volume of distribution changes are not the
primary concern with DOAC dosing.
Q2: A nurse practitioner is called to the newborn nursery to evaluate a 3-day-old term infant whose mother
received a sulfonamide shortly before delivery. The APRN explains that neonates are at unique risk for
kernicterus when sulfonamides are administered because of which age-related pharmacokinetic difference?
A. Enhanced renal tubular reabsorption traps sulfonamide in the central nervous system
B. Accelerated hepatic conjugation increases sulfonamide metabolite formation that is directly neurotoxic
C. Reduced plasma protein binding capacity displaces bilirubin from albumin, allowing free bilirubin to
cross the immature blood-brain barrier [CORRECT]
D. Increased total body fat concentrates lipophilic sulfonamide in neural tissue
Correct Answer: C
Rationale: Neonates have reduced albumin levels and lower binding capacity, so highly protein-bound drugs such as
sulfonamides displace bilirubin; free bilirubin then crosses the immature blood-brain barrier and deposits in the basal
ganglia, causing kernicterus. Option B is wrong because neonatal hepatic conjugation (especially glucuronidation) is
reduced, not accelerated. Option A is incorrect because neonatal renal tubular function is immature, reducing rather
than enhancing reabsorption. Option D is wrong because neonates have increased total body WATER, not fat.
Advanced Practice Nursing Education | Edition 2
, NR 566 Final Exam | Advanced Pharmacology for Care of the Family
Q3: A family nurse practitioner student asks why a drug with a half-life of 24 hours is said to take
approximately 5 days to reach a steady-state serum concentration when a fixed dosing regimen is started.
Which response by the APRN is MOST accurate?
A. Steady state is achieved after approximately four to five half-lives, when the amount administered
equals the amount eliminated per unit time [CORRECT]
B. Steady state is reached after the liver upregulates metabolizing enzymes, which takes five half-lives
C. Steady state depends on reaching peak plasma levels above the minimum toxic concentration
D. Steady state occurs only when the loading dose equals twice the maintenance dose
Correct Answer: A
Rationale: Regardless of dose or route, a drug reaches steady state in approximately 4 to 5 half-lives because
accumulation continues until the rate of administration equals the rate of elimination; a 24-hour half-life therefore
requires about 4 to 5 days. Option B incorrectly attributes steady state to enzyme induction, which is a separate
pharmacogenetic phenomenon. Option C confuses steady state with toxicity. Option D is wrong because loading
doses simply shorten time to steady state and are not mathematically tied to twice the maintenance dose.
Q4: A 55-year-old man with unstable angina is instructed to place sublingual nitroglycerin under his tongue
during chest pain rather than swallowing an oral tablet. The APRN explains that the sublingual route is
preferred primarily because of which pharmacokinetic principle?
A. Sublingual administration increases the first-pass effect, generating a more active metabolite
B. Sublingual absorption is independent of blood flow to the mucosa
C. Sublingual administration avoids hepatic first-pass metabolism, delivering the drug directly into
systemic circulation [CORRECT]
D. Oral nitroglycerin is completely destroyed by gastric acid before absorption
Correct Answer: C
Rationale: Nitroglycerin undergoes extensive first-pass metabolism by the liver when swallowed, leaving very little
active drug in systemic circulation; the sublingual route allows direct absorption into the superior vena cava,
bypassing the portal circulation. Option A reverses the principle, as the goal is to AVOID first-pass metabolism.
Option B is incorrect because sublingual absorption is highly dependent on mucosal blood flow. Option D is wrong
because nitroglycerin is well absorbed orally but deactivated by hepatic metabolism, not gastric acid.
Q5: A patient stabilized on warfarin for atrial fibrillation is started on trimethoprim-sulfamethoxazole for
uncomplicated cystitis. Three days later the patient presents with gum bleeding and an INR of 6.8. Which
pharmacokinetic interaction BEST explains this presentation?
A. The antibiotic increases warfarin clearance through enzyme induction
B. The antibiotic competes for renal tubular secretion, raising warfarin levels
C. The antibiotic reduces warfarin bioavailability by binding it in the gastrointestinal tract
D. The antibiotic displaces warfarin from plasma albumin binding sites while also inhibiting its hepatic
metabolism (CYP2C9), increasing free drug concentration [CORRECT]
Correct Answer: D
Rationale: Trimethoprim-sulfamethoxazole is a classic double-hit interaction: it displaces highly protein-bound
warfarin from albumin and inhibits CYP2C9, increasing free warfarin levels and the INR with bleeding risk. Option
A is incorrect because the interaction involves inhibition, not induction. Option B describes competition for tubular
secretion, which is relevant to drugs such as methotrexate, not warfarin. Option C is incorrect because
co-trimoxazole raises warfarin exposure rather than reducing bioavailability.
Advanced Practice Nursing Education | Edition 3
VERIFIED ANSWERS
NR 566 Final Exam
Questions & Answers
Two hundred verified multiple-choice
questions with detailed rationales covering
advanced pharmacology for care of the family
across the lifespan — aligned with 2026–2027
clinical practice guidelines and course
objectives.
Advanced Pharmacology for Care of the
Family
200 Questions | 10 Sections | Prescriptive Practice
Rationales
L AT E S T 2 0 2 0 2 7 E D I T I O N
,NR 566 Final Exam | Advanced Pharmacology for Care of the Family
Table of Contents
NR 566 / NR566 Final Examination Preparation and Verified Answer Development | Two Hundred Questions Across
Ten Sections, Latest Edition
Section 1: Pharmacokinetics and Pharmacodynamics Across the Lifespan 2
Section 2: Pharmacogenomics and Precision Medicine 10
Section 3: Cardiovascular Pharmacology 14
Section 4: Respiratory Pharmacology 24
Section 5: Endocrine Pharmacology 30
Section 6: Central Nervous System Pharmacology 39
Section 7: Infectious Disease Pharmacology 47
Section 8: Gastrointestinal and Genitourinary Pharmacology 55
Section 9: Pain Management and Anti-Inflammatory Pharmacology 60
Section 10: Special Populations, Safety, and Prescriptive Authority 68
Advanced Practice Nursing Education | Edition 1
,NR 566 Final Exam | Advanced Pharmacology for Care of the Family
SECTION 1
Section 1: Pharmacokinetics and Pharmacodynamics Across the
Lifespan
Absorption, Distribution, Metabolism, Excretion, and Age-Related Considerations
Questions 1 - 20 | 20 Questions | Multiple Choice (A-D), One Best Answer
Q1: A 78-year-old woman with chronic kidney disease (estimated creatinine clearance 28 mL/min), type 2
diabetes, and hypertension requires a new prescription for a direct-acting oral anticoagulant after atrial
fibrillation is diagnosed. As the APRN, which pharmacokinetic principle is the MOST important
determinant of your final dosing decision?
A. Hepatic enzyme induction accelerates drug metabolism in older adults with renal disease
B. Increased gastric pH in older adults substantially reduces drug absorption of DOACs
C. Hypoalbuminemia increases the volume of distribution of all oral anticoagulants by 50%
D. Renal excretion is the primary elimination pathway for apixaban and dabigatran, requiring dose
reduction or alternative selection [CORRECT]
Correct Answer: D
Rationale: Dabigatran (approximately 80%) and apixaban (approximately 27%) rely partly or largely on renal
excretion, so reduced creatinine clearance mandates dose reduction (e.g., apixaban 2.5 mg twice daily when 2 of 3
criteria are met) or selection of an alternative. Option A describes enzyme induction, which is not characteristic of
aging; metabolism of phase I reactions typically declines with age. Option B is incorrect because DOAC absorption
is not meaningfully dependent on gastric pH, which does rise in older adults but affects only certain drugs such as
ketoconazole. Option C overstates the effect of hypoalbuminemia and volume of distribution changes are not the
primary concern with DOAC dosing.
Q2: A nurse practitioner is called to the newborn nursery to evaluate a 3-day-old term infant whose mother
received a sulfonamide shortly before delivery. The APRN explains that neonates are at unique risk for
kernicterus when sulfonamides are administered because of which age-related pharmacokinetic difference?
A. Enhanced renal tubular reabsorption traps sulfonamide in the central nervous system
B. Accelerated hepatic conjugation increases sulfonamide metabolite formation that is directly neurotoxic
C. Reduced plasma protein binding capacity displaces bilirubin from albumin, allowing free bilirubin to
cross the immature blood-brain barrier [CORRECT]
D. Increased total body fat concentrates lipophilic sulfonamide in neural tissue
Correct Answer: C
Rationale: Neonates have reduced albumin levels and lower binding capacity, so highly protein-bound drugs such as
sulfonamides displace bilirubin; free bilirubin then crosses the immature blood-brain barrier and deposits in the basal
ganglia, causing kernicterus. Option B is wrong because neonatal hepatic conjugation (especially glucuronidation) is
reduced, not accelerated. Option A is incorrect because neonatal renal tubular function is immature, reducing rather
than enhancing reabsorption. Option D is wrong because neonates have increased total body WATER, not fat.
Advanced Practice Nursing Education | Edition 2
, NR 566 Final Exam | Advanced Pharmacology for Care of the Family
Q3: A family nurse practitioner student asks why a drug with a half-life of 24 hours is said to take
approximately 5 days to reach a steady-state serum concentration when a fixed dosing regimen is started.
Which response by the APRN is MOST accurate?
A. Steady state is achieved after approximately four to five half-lives, when the amount administered
equals the amount eliminated per unit time [CORRECT]
B. Steady state is reached after the liver upregulates metabolizing enzymes, which takes five half-lives
C. Steady state depends on reaching peak plasma levels above the minimum toxic concentration
D. Steady state occurs only when the loading dose equals twice the maintenance dose
Correct Answer: A
Rationale: Regardless of dose or route, a drug reaches steady state in approximately 4 to 5 half-lives because
accumulation continues until the rate of administration equals the rate of elimination; a 24-hour half-life therefore
requires about 4 to 5 days. Option B incorrectly attributes steady state to enzyme induction, which is a separate
pharmacogenetic phenomenon. Option C confuses steady state with toxicity. Option D is wrong because loading
doses simply shorten time to steady state and are not mathematically tied to twice the maintenance dose.
Q4: A 55-year-old man with unstable angina is instructed to place sublingual nitroglycerin under his tongue
during chest pain rather than swallowing an oral tablet. The APRN explains that the sublingual route is
preferred primarily because of which pharmacokinetic principle?
A. Sublingual administration increases the first-pass effect, generating a more active metabolite
B. Sublingual absorption is independent of blood flow to the mucosa
C. Sublingual administration avoids hepatic first-pass metabolism, delivering the drug directly into
systemic circulation [CORRECT]
D. Oral nitroglycerin is completely destroyed by gastric acid before absorption
Correct Answer: C
Rationale: Nitroglycerin undergoes extensive first-pass metabolism by the liver when swallowed, leaving very little
active drug in systemic circulation; the sublingual route allows direct absorption into the superior vena cava,
bypassing the portal circulation. Option A reverses the principle, as the goal is to AVOID first-pass metabolism.
Option B is incorrect because sublingual absorption is highly dependent on mucosal blood flow. Option D is wrong
because nitroglycerin is well absorbed orally but deactivated by hepatic metabolism, not gastric acid.
Q5: A patient stabilized on warfarin for atrial fibrillation is started on trimethoprim-sulfamethoxazole for
uncomplicated cystitis. Three days later the patient presents with gum bleeding and an INR of 6.8. Which
pharmacokinetic interaction BEST explains this presentation?
A. The antibiotic increases warfarin clearance through enzyme induction
B. The antibiotic competes for renal tubular secretion, raising warfarin levels
C. The antibiotic reduces warfarin bioavailability by binding it in the gastrointestinal tract
D. The antibiotic displaces warfarin from plasma albumin binding sites while also inhibiting its hepatic
metabolism (CYP2C9), increasing free drug concentration [CORRECT]
Correct Answer: D
Rationale: Trimethoprim-sulfamethoxazole is a classic double-hit interaction: it displaces highly protein-bound
warfarin from albumin and inhibits CYP2C9, increasing free warfarin levels and the INR with bleeding risk. Option
A is incorrect because the interaction involves inhibition, not induction. Option B describes competition for tubular
secretion, which is relevant to drugs such as methotrexate, not warfarin. Option C is incorrect because
co-trimoxazole raises warfarin exposure rather than reducing bioavailability.
Advanced Practice Nursing Education | Edition 3
